Display options
Cite
Perrone-Filardi P, Coca A, Galderisi M, et al. Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension. J Hypertens. 2017;35(9):1727-1741doi: 10.1097/HJH.0000000000001396.
Perrone-Filardi, P., Coca, A., Galderisi, M., Paolillo, S., Alpendurada, F., de Simone, G., Donal, E., Kahan, T., Mancia, G., Redon, J., Schmieder, R., Williams, B., & Agabiti-Rosei, E. (2017). Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension. Journal of hypertension, 35(9), 1727-1741. https://doi.org/10.1097/HJH.0000000000001396
Perrone-Filardi, Pasquale, et al. "Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension." Journal of hypertension vol. 35,9 (2017): 1727-1741. doi: https://doi.org/10.1097/HJH.0000000000001396
Perrone-Filardi P, Coca A, Galderisi M, Paolillo S, Alpendurada F, de Simone G, Donal E, Kahan T, Mancia G, Redon J, Schmieder R, Williams B, Agabiti-Rosei E. Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension. J Hypertens. 2017 Sep;35(9):1727-1741. doi: 10.1097/HJH.0000000000001396. PMID: 28767484.
Copy Download .nbib Format: NLM
Share it on

J Hypertens. 2017 Sep;35(9):1727-1741. doi: 10.1097/HJH.0000000000001396.

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension.

Journal of hypertension

Pasquale Perrone-Filardi, Antonio Coca, Maurizio Galderisi, Stefania Paolillo, Francisco Alpendurada, Giovanni de Simone, Erwan Donal, Thomas Kahan, Giuseppe Mancia, Josep Redon, Roland Schmieder, Bryan Williams, Enrico Agabiti-Rosei

Affiliations

  1. aDepartment of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy bHypertension and Vascular Risk Unit, Department of Internal Medicine, Hospital Clínic (IDIBAPS), University of Barcelona, Barcelona, Spain cSDN IRCCS, Naples, Italy dNIHR Cardiovascular BRU, Royal Brompton & Harefield NHS Trust and Imperial College London, London, United Kingdom eHypertension Research Center (CIRIAPA), Federico II University of Naples, Naples, Italy fCardiology & Cic-it 1414, CHU Rennes LTSI, Insert 1099, Université Rennes-1, Rennes, France gDivision of Cardiovascular Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden hIRCCS Istituto Auxologico Italiano e Istituto Clinico Universitario di Verano Brianza, Policlinico di Monza, Monza, Italy iINCLIVA Research Institute, University of Valencia and CIBERObn Carlos III Institute, Madrid, Spain jDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany kUniversity College London and National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom lDepartment of Clinical and Experimental Sciences, Clinica Medica, Hypertension and Cardiovascular Risk Research Centre, University of Brescia, Spedali Civili, Brescia, Italy.

PMID: 28767484 DOI: 10.1097/HJH.0000000000001396

Abstract

: Arterial hypertension accounts for the largest amount of attributable cardiovascular mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by hypertension represents an independent determinant of cardiovascular risk, and the identification of target organ damage is recommended to further reclassify patients' risk. Noninvasive cardiovascular imaging is progressively being used and continues to provide new technological opportunities to target organ damage evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of noninvasive imaging tests in the growing population of hypertensive patients.

MeSH terms

Publication Types

Grant support